
PRECISION Study Published in ESMO Open Demonstrates Guardant360 and Guardant Reveal’s Role in Assessing Colorectal Cancer Recurrence Risk After Surgery
PRECISION Study Highlights Potential of Guardant Liquid Biopsy Tests to Predict Colorectal Cancer Recurrence Risk After Surgery Guardant Health, a precision oncology company focused on advancing cancer care through innovative blood-based testing technologies, has announced the publication of new clinical…













